Gastric adenomas: Relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression

Annals of Oncology

Volumn 17, Issue SUPPL. 7, 2006, Pages

  Rocco, A ^a   Caruso, S ^b   Toracchio, S ^b,c   Rigoli, L ^b   Verginelli, F ^b,c   Catalano, T ^d   Neri, M ^c   Curia, M C ^b,c   Ottini, L ^e   Agnese, V ^f   Bazan, V ^f   Russo, A ^f   Pantuso, G ^f   Colucci, G ^g   Mariani Contantini, R ^b,c   Nardone, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Department of Human Pathology ^*  (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

^g NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

APC mutations; COX 2; Gastric adenoma; Helicobacter pylori

Indexed keywords

APC PROTEIN; CYCLOOXYGENASE 2;

ADENOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CODON; DISEASE ASSOCIATION; FEMALE; GENE CLUSTER; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOMA; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; FEMALE; GASTRIC MUCOSA; GENES, APC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; MUTATION; STOMACH NEOPLASMS;

EID: 33745601129     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl961     Document Type: Article

References (44)

1. Abraham SC, Montgomery EA, Singh VK et al. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002; 26: 1276-1285.
2. Takenawa H, Kurosaki M, Enomoto N et al. Differential gene-expression profiles associated with gastric adenoma. Br J Cancer 2004; 90: 216-223.
3. Kamiya T, Morishita T, Asakura H et al. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer 1982; 50: 2496-2503.
4. Kolodziejczyk P, Yao T, Oya M et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer 1994; 74: 2896-2907.
5. Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 1995; 90: 2152-2159.
6. Tsujitani S, Furusawa M, Hayashi I. Morphological factors aid in therapeutic decisions concerning gastric adenomas. Hepatogastroenterology 1992; 39: 56-58.
7. Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255.
8. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut 1999; 45: 784-790.
9. Abraham SC, Nobukawa B, Giardiello FM et al. Fundic gland polyps in familial adenomatous polyposis: Neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 2000; 157: 747-754.
10. Sieber OM, Lipton L, Crabtree M et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348: 791-799.
11. Lamlum H, Papadopoulou A, Ilyas M et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 2000; 97: 2225-2228.
12. Elder DJ, Baker JA, Banu NA et al. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J Pathol 2002; 198: 428-434.
13. Eberhart CE, Coffey RJ, Radhika A et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.
14. Fitzpatrick FA, Soberman R. Regulated formation of eicosanoids. J Clin Invest 2001; 107: 1347-1351.
15. L: A molecular pathway of H. pylori-related gastric carcinogenesis. J Pathol 2004; 202: 305-312.
16. Sung JJ, Leung WK, Go MY et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000; 157: 729-735.
17. Ristimaki A, Honkanen N, Jankala H et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997; 57: 1276-1280.
18. Saukkonen K, Nieminen O, van Rees B et al. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin Cancer Res 2001; 7: 1923-1931.
19. Yamagata R, Shimoyama T, Fukuda S et al. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol 2002; 14: 359-363.
20. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362.
21. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-1179.
22. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association-of Helicobacter pylori infection with gastric carcinoma: A meta-analysis. Am J Gastroenterol 1999; 94: 2373-2379.
23. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
24. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
25. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. Am J Surg Pathol 1996; 20: 1161-1181.
26. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965; 64: 31-49.
27. Ottini L, Palli D, Falchetti M et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997; 57: 4523-4529.
28. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
29. Sporn MB, Liby KT. Cancer chemoprevention: Scientific promise, clinical uncertainty. Nat Clin Pract Oncol 2005; 2: 518-525.
30. Guindi M, Riddell RH. The pathology of epithelial pre-malignancy of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2001; 15: 191-210.
31. Yoshida S, Saito D. Gastric premalignancy and cancer screening in high-risk patients. Am J Gastroenterol 1996; 91: 839-843.
32. Ginsberg GG, Al-Kawas FH, Fleischer DE et al. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol 1996; 91: 714-717.
33. Kolodziejczyk P, Yao T, Oya M et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer 1994; 74: 2896-2907.
34. Laxen F, Sipponen P, Ihamaki T et al. Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand 1982; 90: 221-228.
35. Nakamura K, Sakaguchi H, Enjoji M. Depressed adenoma of the stomach. Cancer 1988; 62: 2197-2202.
36. Pisano R, Llorens P, Backhouse C, Palma M. Anatomopathological study of 86 gastric adenomas. Experience in 14 years. Rev Med Chil 1996; 124: 204-208.
37. Sakurai S, Sano T, Nakajima T. Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality. Pathol Int 1995; 45: 51-57.
38. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy 1995; 27: 32-37.
39. Gotoda T, Saito D, Kondo H et al. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. J Gastroenterol 1999; 34 (Suppl 11): 91-96.
40. Komoto K, Haruma K, Kamada T et al. Helicobacter pylori infection and gastric neoplasia: Correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93: 1271-1276.
41. Nakano H, Persson B, Slezak P. Study of the gastric mucosal background in patients with gastric polyps. Gastrointest Endosc 1990; 36: 39-42.
42. Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 18: 426-440.
43. Lee JH, Abraham SC, Kim HS et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002; 161: 611-618.
44. Wang O, Dubois RN. Prostaglandins and cancer. Gut 2006; 55: 115-122.